Clinical Trial Update: The Effect of Melatonin Administration on Sedation Level as Adjuvant to Propofol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating melatonin as an adjuvant to propofol for sedation in traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Melatonin (melatonin)
• PROPOFOL (Propofol)

Snippet

Sponsor: Cairo University | Conditions: TBI (Traumatic Brain Injury) | Phase 3 | Status: COMPLETED